Unknown

Dataset Information

Hypouricemic and arthritis relapse-reducing effects of compound tufuling oral-liquid in intercritical and chronic gout: A double-blind, placebo-controlled, multicenter randomized trial.


ABSTRACT:

Trial design

In the double-blind, randomized, controlled trial, we aimed to evaluate the effects of compound tufuling oral liquid (CoTOL) on serum uric acid (sUA) levels and recurrence of acute gouty arthritis in intercritical and chronic gout treatment.

Methods

A total of 210 patients with gout were screened from 8 hospitals to observe the sUA and acute gouty arthritis recurrence rate-reducing effects of CoTOL in intercritical and chronic gout during a 12-week treatment. We treated 139 and 71 patients with CoTOL and the placebo, respectively, and evaluated their sUA levels, acute gouty arthritis recurrence rate, and adverse events at week 0, 6, and 12.

Results

Twenty-five and 12 patients in the treatment and control groups, respectively, had interrupted treatments, w

SUBMITTER: Xie Z 

PROVIDER: S-EPMC5369899 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature